Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yusuke Higuchi

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Cancers|December 10, 2021
Differential Kat3 Usage Orchestrates the Integration of Cellular Metabolism with DifferentiationXiaohui Hu, Masaya Ono, Nyam-Osor Chimge, et al.
Cell Chemical Biology|May 2, 2023
IFNα primes cancer cells for Fusicoccin-induced cell death via 14-3-3 PPI stabilizationBlaž Andlovic, Geronimo Heilmann, Sabrina Ninck, et al.
Blood Cell Therapy|December 10, 2025
Adult-Onset Epstein-Barr Virus-Associated T-Cell Lymphoproliferative Disease with Central Nervous System InvolvementAtsushi Wada, Hiro Tatetsu, Shinya Endo, et al.
Nature Communications|June 22, 2021
Engineered ACE2 receptor therapy overcomes mutational escape of SARS-CoV-2Yusuke Higuchi, Tatsuya Suzuki, Takao Arimori, et al.
Science Translational Medicine|April 26, 2022
An engineered ACE2 decoy neutralizes the SARS-CoV-2 Omicron variant and confers protection against infection in vivoNariko Ikemura, Shunta Taminishi, Tohru Inaba, et al.
Plos Pathogens|November 30, 2017
Human T-cell leukemia virus type 1 infects multiple lineage hematopoietic cells in vivoRie Furuta, Jun-Ichirou Yasunaga, Michi Miura, et al.
Cancers|April 3, 2021
p300 Serine 89: A Critical Signaling Integrator and Its Effects on Intestinal Homeostasis and RepairKeane K Y Lai, Xiaohui Hu, Keisuke Chosa, et al.
Nature Communications|July 14, 2023
Structural delineation and computational design of SARS-CoV-2-neutralizing antibodies against Omicron subvariantsSaya Moriyama, Yuki Anraku, Shunta Taminishi, et al.
Science Translational Medicine|August 30, 2023
An inhaled ACE2 decoy confers protection against SARS-CoV-2 infection in preclinical modelsEmiko Urano, Yumi Itoh, Tatsuya Suzuki, et al.
Blood Advances|April 17, 2026
Long-read KIR genotyping reveals donor KIR/HLA polymorphisms linked to posttransplant relapse in T-cell malignanciesMari Morita-Fujita, Shuji Kawaguchi, Takero Shindo, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Cancers|December 10, 2021
Differential Kat3 Usage Orchestrates the Integration of Cellular Metabolism with DifferentiationXiaohui Hu, Masaya Ono, Nyam-Osor Chimge, et al.
Cell Chemical Biology|May 2, 2023
IFNα primes cancer cells for Fusicoccin-induced cell death via 14-3-3 PPI stabilizationBlaž Andlovic, Geronimo Heilmann, Sabrina Ninck, et al.
Blood Cell Therapy|December 10, 2025
Adult-Onset Epstein-Barr Virus-Associated T-Cell Lymphoproliferative Disease with Central Nervous System InvolvementAtsushi Wada, Hiro Tatetsu, Shinya Endo, et al.
Nature Communications|June 22, 2021
Engineered ACE2 receptor therapy overcomes mutational escape of SARS-CoV-2Yusuke Higuchi, Tatsuya Suzuki, Takao Arimori, et al.
Science Translational Medicine|April 26, 2022
An engineered ACE2 decoy neutralizes the SARS-CoV-2 Omicron variant and confers protection against infection in vivoNariko Ikemura, Shunta Taminishi, Tohru Inaba, et al.
Plos Pathogens|November 30, 2017
Human T-cell leukemia virus type 1 infects multiple lineage hematopoietic cells in vivoRie Furuta, Jun-Ichirou Yasunaga, Michi Miura, et al.
Cancers|April 3, 2021
p300 Serine 89: A Critical Signaling Integrator and Its Effects on Intestinal Homeostasis and RepairKeane K Y Lai, Xiaohui Hu, Keisuke Chosa, et al.
Nature Communications|July 14, 2023
Structural delineation and computational design of SARS-CoV-2-neutralizing antibodies against Omicron subvariantsSaya Moriyama, Yuki Anraku, Shunta Taminishi, et al.
Science Translational Medicine|August 30, 2023
An inhaled ACE2 decoy confers protection against SARS-CoV-2 infection in preclinical modelsEmiko Urano, Yumi Itoh, Tatsuya Suzuki, et al.
Blood Advances|April 17, 2026
Long-read KIR genotyping reveals donor KIR/HLA polymorphisms linked to posttransplant relapse in T-cell malignanciesMari Morita-Fujita, Shuji Kawaguchi, Takero Shindo, et al.
Pageof 9